Appointments

Woebot appoints Trina Histon VP of Clinical Product Strategy

Published

on

Woebot Health has announced the appointment of Trina Histon, PhD, as Vice President of Clinical Product Strategy.

The role will see Histon accelerate Woebot’s capabilities to integrate into care pathways and advance the software transformation of psychiatry, behavioural health and primary care.

Histon’s experience in embedding and deploying digital health solutions in care delivery spans more than two decades.

Prior joining Woebot Health, Histon was a Senior Principal Consultant in Kaiser Permanente’s Care Management Institute (CMI).

There, he helped shape the strategic direction, management and performance of wellness and prevention activities and also led efforts to build, test and scale a digital mental health ecosystem across all Kaiser Permanente markets.

Chief Product Officer Joe Gallagher, PhD, said:

“Trina is one of the few people in our industry who has consistently been at the forefront of digital behavioural health, and will bring unparalleled experience evaluating and implementing innovative solutions to our work.

“We are fortunate that a person with such an impressive track record will now help shape our approach to making behavioural health an integral and easily integrated part of the care practice and experience.”

Histon is the author of dozens of scientific papers focused on prevention and wellness, including a recent case study in the New England Journal of Medicine’s Catalyst.

He holds a doctorate degree in Health Psychology and a bachelor’s degree in Applied Psychology from University College Cork, Ireland.

Histon said:

“In my previous roles, I’ve assessed many digital behavioral health solutions.

“Woebot always stood out for its clinical focus and its ability to build trust and deliver the right tool for the moment, so that people can take that next step to feeling better.

“I’m thrilled to join this talented team and to share the goal to reduce the burden of suffering for people who are living with anxiety and depression.”

Click to comment

Trending stories

Exit mobile version